Astellas Pharma Shares Outstanding 2012-2020 | ALPMY

Astellas Pharma shares outstanding history from 2012 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Astellas Pharma shares outstanding for the quarter ending September 30, 2020 were M, a 100% decline year-over-year.
  • Astellas Pharma 2020 shares outstanding were 1.878B, a 2.91% decline from 2019.
  • Astellas Pharma 2019 shares outstanding were 1.934B, a 4.86% decline from 2018.
  • Astellas Pharma 2018 shares outstanding were 2.032B, a 4.26% decline from 2017.
Astellas Pharma Annual Shares Outstanding
(Millions of Shares)
2020 1,878
2019 1,934
2018 2,032
2017 2,123
2016 2,161
2015 2,212
2014 2,247
2013 2,294
2012 2,340
2011 2,340
2010 2,380
2009 2,520
2008 2,595
2007 2,689
2006 2,819
Astellas Pharma Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30
2020-06-30 1,859
2019-06-30 1,888
2018-06-30 2,008
2017-06-30 2,066
2016-09-30 2,160
2016-06-30 2,127
2016-03-31 2,161
2015-12-31 2,170
2015-09-30 2,179
2015-06-30 2,190
2015-03-31 2,212
2014-12-31 2,216
2014-09-30 2,217
2014-06-30 2,223
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $28.188B $11.967B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.646B 42.46
Takeda Pharmaceutical (TAK) Japan $53.647B 9.83
Eisai (ESALY) Japan $19.710B 21.86
Catalent (CTLT) United States $18.562B 49.12
Grifols, S.A (GRFS) Spain $12.273B 14.28
Jazz Pharmaceuticals (JAZZ) Ireland $9.199B 15.36
United Therapeutics (UTHR) United States $8.878B 17.24
Neurocrine Biosciences (NBIX) United States $8.789B 20.25
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.479B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.635B 0.00
Evotec AG (EVTCY) Germany $6.555B 442.61
Orion OYJ (ORINY) Finland $5.789B 20.11
Ionis Pharmaceuticals (IONS) United States $5.788B 0.00
Sage Therapeutics (SAGE) United States $4.200B 0.00
Hypermarcas (HYPMY) Brazil $3.984B 15.73
Turning Point Therapeutics (TPTX) United States $3.664B 0.00
Nektar Therapeutics (NKTR) United States $3.407B 0.00
PTC Therapeutics (PTCT) United States $3.327B 0.00
ChemoCentryx (CCXI) United States $3.290B 0.00
Tilray (TLRY) Canada $3.147B 0.00
Cronos Group (CRON) Canada $3.030B 0.00
Pacira BioSciences (PCRX) United States $2.994B 50.56
Relay Therapeutics (RLAY) United States $2.890B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.770B 17.15
Revolution Medicines (RVMD) United States $2.758B 0.00
Organogenesis Holdings (ORGO) United States $2.700B 162.31
Corcept Therapeutics (CORT) United States $2.614B 26.21
Xencor (XNCR) United States $2.330B 0.00
USANA Health Sciences (USNA) United States $2.069B 17.12
FibroGen (FGEN) United States $1.806B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.727B 11.08
BioCryst Pharmaceuticals (BCRX) United States $1.719B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.660B 13.05
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.630B 0.00
Sundial Growers (SNDL) Canada $1.627B 0.00
AlloVir (ALVR) United States $1.541B 0.00
Heron Therapeutics (HRTX) United States $1.523B 0.00
ImmunoGen (IMGN) United States $1.452B 0.00
Endo (ENDP) Ireland $1.408B 2.13
Aclaris Therapeutics (ACRS) United States $1.371B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.342B 0.00
Indivior (INVVY) United States $1.333B 0.00
Translate Bio (TBIO) United States $1.310B 0.00
Ocular Therapeutix (OCUL) United States $1.209B 0.00
Zogenix (ZGNX) United States $1.064B 0.00
Trillium Therapeutics (TRIL) Canada $1.038B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.997B 0.00
4D Molecular Therapeutics (FDMT) $0.954B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.886B 0.00
Aerie Pharmaceuticals (AERI) United States $0.875B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Bioventus (BVS) United States $0.814B 0.00
Collegium Pharmaceutical (COLL) United States $0.807B 30.15
Karyopharm Therapeutics (KPTI) United States $0.758B 0.00
Esperion Therapeutics (ESPR) United States $0.732B 0.00
Ardelyx (ARDX) United States $0.711B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Rafael Holdings (RFL) United States $0.672B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.667B 0.00
VAXART, INC (VXRT) United States $0.650B 0.00
Harpoon Therapeutics (HARP) United States $0.644B 0.00
KalVista Pharmaceuticals (KALV) United States $0.636B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.614B 0.00
Chinook Therapeutics (KDNY) United States $0.589B 0.00
Sigilon Therapeutics (SGTX) $0.587B 0.00
Siga Technologies (SIGA) United States $0.540B 9.01
Nanobiotix S.A (NBTX) France $0.539B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.518B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.499B 0.00
TherapeuticsMD (TXMD) United States $0.495B 0.00
Altimmune (ALT) United States $0.471B 0.00
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.456B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.455B 10.68
Foghorn Therapeutics (FHTX) United States $0.450B 0.00
AVITA Medical (RCEL) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.446B 0.00
Molecular Templates (MTEM) United States $0.441B 0.00
Jounce Therapeutics (JNCE) United States $0.420B 0.00
PROFOUND MEDICL (PROF) Canada $0.415B 0.00
MEI Pharma (MEIP) United States $0.399B 0.00
DURECT (DRRX) United States $0.398B 0.00
Nature's Sunshine Products (NATR) United States $0.387B 18.44
Acutus Medical (AFIB) United States $0.370B 0.00
Innate Pharma SA (IPHYF) France $0.347B 0.00
Redhill Biopharma (RDHL) Israel $0.332B 0.00
Oncternal Therapeutics (ONCT) United States $0.317B 0.00
Clever Leaves Holdings (CLVR) United States $0.311B 0.00
VYNE Therapeutics (VYNE) United States $0.289B 0.00
Infinity Pharmaceuticals (INFI) United States $0.269B 0.00
CASI Pharmaceuticals (CASI) United States $0.266B 0.00
Taiwan Liposome (TLC) Taiwan $0.250B 0.00
Alpine Immune Sciences (ALPN) United States $0.250B 0.00
KemPharm (KMPH) United States $0.245B 0.00
Xeris Pharmaceuticals (XERS) United States $0.237B 0.00
Inotiv (NOTV) United States $0.233B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.226B 0.00
Iterum Therapeutics (ITRM) Ireland $0.224B 0.00
Jaguar Animal Health (JAGX) United States $0.220B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.218B 0.00
Progenity (PROG) United States $0.212B 0.00
Sierra Oncology (SRRA) Canada $0.210B 0.00
Novan (NOVN) United States $0.202B 0.00
Lannett Co Inc (LCI) United States $0.201B 6.75
Oasmia Pharmaceutical AB (OASMY) Sweden $0.200B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.198B 0.00
OptiNose (OPTN) United States $0.187B 0.00
CTI BioPharma (CTIC) United States $0.185B 0.00
IMV INC (IMV) Canada $0.185B 0.00
Heat Biologics (HTBX) United States $0.170B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.166B 0.00
Adherex Technologies (FENC) United States $0.164B 0.00
Calithera Biosciences (CALA) United States $0.159B 0.00
SCYNEXIS (SCYX) United States $0.159B 0.00
Onconova Therapeutics (ONTX) United States $0.159B 0.00
Vivos Therapeutics (VVOS) $0.158B 0.00
Qilian Holding Group (QLI) China $0.156B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Concert Pharmaceuticals (CNCE) United States $0.149B 0.00
IsoRay (ISR) United States $0.147B 0.00
MediWound (MDWD) Israel $0.139B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
Aziyo Biologics (AZYO) United States $0.134B 0.00
Nutriband (NTRB) United States $0.133B 0.00
Lipocine (LPCN) United States $0.131B 0.00
GlycoMimetics (GLYC) United States $0.130B 0.00
Genocea Biosciences (GNCA) United States $0.123B 0.00
PolarityTE (PTE) United States $0.117B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.110B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Natural Alternatives (NAII) United States $0.107B 29.14
Otonomy (OTIC) United States $0.105B 0.00
Minerva Neurosciences (NERV) United States $0.103B 40.33
AIM ImmunoTech (AIM) United States $0.103B 0.00
Savara (SVRA) United States $0.098B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.095B 0.00
Recro Pharma (REPH) United States $0.091B 0.00
Assertio Holdings (ASRT) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Regulus Therapeutics (RGLS) United States $0.086B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
ProPhase Labs (PRPH) United States $0.077B 0.00
Baudax Bio (BXRX) United States $0.077B 0.00
India Globalization Capital (IGC) United States $0.073B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.069B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Sigyn Therapeutics (SIGY) United States $0.062B 0.00
Brickell Biotech (BBI) United States $0.061B 0.00
AgeX Therapeutics (AGE) United States $0.060B 0.00
Biomerica (BMRA) United States $0.058B 0.00
IntelGenx Technologies (IGXT) Canada $0.058B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.057B 0.00
Inhibikase Therapeutics (IKT) United States $0.055B 0.00
HANCOCK JAFFE (HJLI) United States $0.054B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 62.40
Viracta Therapeutics (VIRX) United States $0.041B 0.00
Mannatech (MTEX) United States $0.040B 7.12
Can-Fite Biopharma (CANF) Israel $0.039B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.034B 0.00
4D Pharma (LBPS) United Kingdom $0.033B 0.00
RXi Pharmaceuticals (PHIO) United States $0.032B 0.00
Petros Pharmaceuticals (PTPI) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
JanOne (JAN) United States $0.021B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 15.75
Xenetic Biosciences (XBIO) United States $0.019B 0.00
SHINECO INC (TYHT) China $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00